Insider Deck research · News

TEV.F stock news · Teva Pharmaceutical Industries Limited

Latest Teva Pharmaceutical Industries Limited (TEV.F) stock news, headlines, and research context on Insider Deck. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Market cap $34B.

News desk

Teva Pharmaceutical Industries Limited wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

10 on the wireUpdated within the hour

Forkast News·Thu, Aug 6, 5:59 AM

Meta’s Superintelligence Labs Ships Its First Product — and the Contributor Tier Is the Real Strategy

The Product-Arm Ships Meta Superintelligence Labs has moved beyond research. On August 5, 2026, the unit Alexandr Wang built after Meta’s ~$14.3 billion acquihire of Scale AI shipped its first commercial product: Muse Code, a terminal-based coding agent powered by the Muse Spark 1.2 model. The launch is less about the agent itself than about […]

Insider Deck desk note

Last$29.20
Day-1.02%
SymbolTEV.F

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on Forkast News

Frequently asked questions

What is the latest news on TEV.F?

The TEV.F news desk aggregates recent headlines with research context for Teva Pharmaceutical Industries Limited (Healthcare).

Where can I research TEV.F on Insider Deck?

Teva Pharmaceutical Industries Limited (TEV.F) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.